CD133 as a marker for cancer stem cells: progresses and concerns.

Increasing evidence supports the cancer stem cell hypothesis, which postulates that cancer stem cells are responsible for tumor initiation, metastasis, and resistance to treatments. Therefore, they are the cells to target to cure a cancer. To study the behavior of cancer stem cells, markers for prospective isolation of cancer stem cells are crucial. Recently, CD133 has been used extensively as a marker for the identification of stem cells from normal and cancerous tissues. Several more recent studies, however, indicate that CD133 are expressed in differentiated epithelial cells in various organs, and CD133-negative cancer cells can also initiate tumors. The findings suggest that CD133 is not restricted to somatic stem cells and cancer stem cells. However, in many cases CD133 may be used in combination with other markers or methods to acquire stem cells. In this review, we summarize findings in CD133 expression in various tissues and critically discuss its applications in stem cell isolation.

[1]  Y. Guan,et al.  Spontaneous transformation of adult mesenchymal stem cells from cynomolgus macaques in vitro. , 2011, Experimental cell research.

[2]  T. Suo,et al.  Arsenic oxide targets stem cell marker CD133/prominin-1 in gallbladder carcinoma. , 2011, Cancer letters.

[3]  M. Salto‐Tellez,et al.  Sequential expression of putative stem cell markers in gastric carcinogenesis , 2011, British Journal of Cancer.

[4]  O. Myklebost,et al.  Liposarcoma cells with aldefluor and CD133 activity have a cancer stem cell potential , 2011, Clinical Sarcoma Research.

[5]  Meng-chao Wu,et al.  Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines , 2011, BMC gastroenterology.

[6]  W. Yeung,et al.  Identification of cells with colony-forming activity, self-renewal capacity, and multipotency in ovarian endometriosis. , 2011, The American journal of pathology.

[7]  H. Ishii,et al.  Combination use of anti‐CD133 antibody and SSA lectin can effectively enrich cells with high tumorigenicity , 2011, Cancer science.

[8]  B. Campos,et al.  CD133/prominin1 is prognostic for GBM patient’s survival, but inversely correlated with cysteine cathepsins’ expression in glioblastoma derived spheroids , 2011, Radiology and oncology.

[9]  Young Nyun Park,et al.  Tudor domain-containing protein 4 as a potential cancer/testis antigen in liver cancer. , 2011, The Tohoku journal of experimental medicine.

[10]  T. Ried,et al.  Genome and transcriptome profiles of CD133-positive colorectal cancer cells. , 2011, The American journal of pathology.

[11]  M. Wong,et al.  Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma , 2010, Journal of oncology.

[12]  I. Pavord,et al.  Extended extraocular phenotype of PROM1 mutation in kindreds with known autosomal dominant macular dystrophy , 2011, European Journal of Human Genetics.

[13]  Z. Yang,et al.  Alpha2,3-Sialylation regulates the stability of stem cell marker CD133. , 2010, Journal of biochemistry.

[14]  Chi-Hung Lin,et al.  Early relapse in a rectal cancer patient: Possible implication of circulating cancer stem cell , 2010, Journal of surgical oncology.

[15]  O. Heidenreich,et al.  Understanding the cancer stem cell , 2010, British Journal of Cancer.

[16]  Chao He,et al.  Quantitative analyses of CD133 expression facilitate researches on tumor stem cells. , 2010, Biological & pharmaceutical bulletin.

[17]  S. Nozell,et al.  NF-κB and STAT3 signaling in glioma: targets for future therapies , 2010, Expert review of neurotherapeutics.

[18]  K. Leong,et al.  Generation of a prostate from a single adult stem cell , 2008, Nature.

[19]  W. Huttner,et al.  The Stem Cell Marker CD133 (Prominin-1) Is Expressed in Various Human Glandular Epithelia , 2008, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[20]  D. Brewer,et al.  Expression profiling of CD133+ and CD133— epithelial cells from human prostate , 2008, The Prostate.

[21]  Ian A. White,et al.  CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. , 2008, The Journal of clinical investigation.

[22]  Mina J Bissell,et al.  Is CD133 a marker of metastatic colon cancer stem cells? , 2008, The Journal of clinical investigation.

[23]  G. Stassi,et al.  Cancer stem cells – old concepts, new insights , 2008, Cell Death and Differentiation.

[24]  K. Wong,et al.  Direct Orthotopic Transplantation of Fresh Surgical Specimen Preserves CD133+ Tumor Cells in Clinically Relevant Mouse Models of Medulloblastoma and Glioma , 2008, Stem cells.

[25]  Yi-Wei Chen,et al.  Identification of CD133-Positive Radioresistant Cells in Atypical Teratoid/ Rhabdoid Tumor , 2008, PloS one.

[26]  Kornelia Polyak,et al.  The cancer stem cell hypothesis: in search of definitions, markers, and relevance , 2008, Laboratory Investigation.

[27]  D. Gisselsson,et al.  Glial Progenitor-Like Phenotype in Low-Grade Glioma and Enhanced CD133-Expression and Neuronal Lineage Differentiation Potential in High-Grade Glioma , 2008, PloS one.

[28]  Jian Wang,et al.  CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells , 2008, International journal of cancer.

[29]  Peter Canoll,et al.  Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas. , 2008, Neurosurgery.

[30]  W. Huttner,et al.  Stem Cell Marker Prominin-1/AC133 Is Expressed in Duct Cells of the Adult Human Pancreas , 2008, Pancreas.

[31]  前田 真一.  CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer , 2008 .

[32]  A. Molven,et al.  Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas , 2008, BMC Cancer.

[33]  D. Wion,et al.  Influence of oxygen tension on CD133 phenotype in human glioma cell cultures. , 2007, Cancer letters.

[34]  Z. Werb,et al.  Location, location, location: the cancer stem cell niche. , 2007, Cell stem cell.

[35]  M. Todaro,et al.  Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. , 2007, Cell stem cell.

[36]  Albert D Donnenberg,et al.  Tumorigenic stem and progenitor cells: implications for the therapeutic index of anti-cancer agents. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[37]  Daniel J. Hoeppner,et al.  Oxygen Tension Regulates Survival and Fate of Mouse Central Nervous System Precursors at Multiple Levels , 2007, Stem cells.

[38]  Nancy Cheng,et al.  Human hepatic stem cells from fetal and postnatal donors , 2007 .

[39]  M. Bissell,et al.  Of Microenvironments and Mammary Stem Cells , 2007, Stem Cell Reviews.

[40]  S. Teitelbaum,et al.  Adult Versus Embryonic Stem Cells: Treatments , 2007, Science.

[41]  I. Ng,et al.  Identification and characterization of tumorigenic liver cancer stem/progenitor cells. , 2007, Gastroenterology.

[42]  A. Harris,et al.  Transcriptional Profiling of Human Cord Blood CD133+ and Cultured Bone Marrow Mesenchymal Stem Cells in Response to Hypoxia , 2007, Stem cells.

[43]  J. Rhim,et al.  Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens. , 2007, Cancer research.

[44]  Caterina A M La Porta,et al.  Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential. , 2007, European journal of cancer.

[45]  N. Ohkohchi,et al.  Isolation of mouse pancreatic ductal progenitor cells expressing CD133 and c-Met by flow cytometric cell sorting. , 2007, Gastroenterology.

[46]  J. Dick,et al.  A human colon cancer cell capable of initiating tumour growth in immunodeficient mice , 2007, Nature.

[47]  L. Ricci-Vitiani,et al.  Identification and expansion of human colon-cancer-initiating cells , 2007, Nature.

[48]  G. Camussi,et al.  Isolation and Characterization of a Stem Cell Population from Adult Human Liver , 2006, Stem cells.

[49]  M. Carini,et al.  Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys. , 2006, Journal of the American Society of Nephrology : JASN.

[50]  B. Hogan,et al.  Epithelial stem cells of the lung: privileged few or opportunities for many? , 2006, Development.

[51]  J. Engelhardt,et al.  Stem cells in the lung. , 2006, Methods in enzymology.

[52]  Nicholas A. Wright,et al.  The gastrointestinal tract stem cell niche , 2006, Stem Cell Reviews.

[53]  W. Huttner,et al.  Isolation of neural stem cells from the postnatal cerebellum , 2005, Nature Neuroscience.

[54]  G. Camussi,et al.  Isolation of renal progenitor cells from adult human kidney. , 2005, The American journal of pathology.

[55]  Zang Ai-hua,et al.  Stem Cells,Cancer and Cancer Stem Cells , 2005 .

[56]  R. Henkelman,et al.  Identification of human brain tumour initiating cells , 2004, Nature.

[57]  W. Huttner,et al.  Identification of novel Prominin-1/CD133 splice variants with alternative C-termini and their expression in epididymis and testis , 2004, Journal of Cell Science.

[58]  D. Neal,et al.  CD133, a novel marker for human prostatic epithelial stem cells , 2004, Journal of Cell Science.

[59]  W. Huttner,et al.  Prominin-1/CD133, a neural and hematopoietic stem cell marker, is expressed in adult human differentiated cells and certain types of kidney cancer , 2004, Cell and Tissue Research.

[60]  M. Raff.  Adult stem cell plasticity: fact or artifact? , 2003, Annual review of cell and developmental biology.

[61]  Cynthia Hawkins,et al.  Identification of a cancer stem cell in human brain tumors. , 2003, Cancer research.

[62]  W. Huttner,et al.  Characterization of Prominin-2, a New Member of the Prominin Family of Pentaspan Membrane Glycoproteins* 210 , 2003, The Journal of Biological Chemistry.

[63]  P. Anversa,et al.  Myocyte renewal and ventricular remodelling , 2002, Nature.

[64]  I. Weissman,et al.  Direct isolation of human central nervous system stem cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[65]  W. Huttner,et al.  Retention of prominin in microvilli reveals distinct cholesterol-based lipid micro-domains in the apical plasma membrane , 2000, Nature Cell Biology.

[66]  W. Huttner,et al.  The Human AC133 Hematopoietic Stem Cell Antigen Is also Expressed in Epithelial Cells and Targeted to Plasma Membrane Protrusions* , 2000, The Journal of Biological Chemistry.

[67]  K. Pantel,et al.  In vitro differentiation of endothelial cells from AC133-positive progenitor cells. , 1999, Blood.

[68]  W. Huttner,et al.  A frameshift mutation in prominin (mouse)-like 1 causes human retinal degeneration. , 2000, Human molecular genetics.

[69]  W. Huttner,et al.  AC133 hematopoietic stem cell antigen: human homologue of mouse kidney prominin or distinct member of a novel protein family? , 1998, Blood.

[70]  J. Kearney,et al.  AC133, a novel marker for human hematopoietic stem and progenitor cells. , 1997, Blood.

[71]  R. Warnke,et al.  A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. , 1997, Blood.

[72]  W. Huttner,et al.  Prominin, a novel microvilli-specific polytopic membrane protein of the apical surface of epithelial cells, is targeted to plasmalemmal protrusions of non-epithelial cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[73]  Brent A. Reynolds,et al.  Multipotent CNS Stem Cells Are Present in the Adult Mammalian Spinal Cord and Ventricular Neuroaxis , 1996, The Journal of Neuroscience.

[74]  Brent A. Reynolds,et al.  Neural stem cells in the adult mammalian forebrain: A relatively quiescent subpopulation of subependymal cells , 1994, Neuron.

[75]  S. Weiss,et al.  Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. , 1992, Science.